Comparative pharmacokinetics of breviscapine liposomes in dogs, rabbits and rats.

[1]  P. Abrams.  Pharmacologic Treatments for Pain Associated With Diabetic Peripheral Neuropathies , 2007 .

[2]  Q. Ping,et al.  Distribution of liposomal breviscapine in brain following intravenous injection in rats. , 2005, International journal of pharmaceutics.

[3]  H. Hong,et al.  Protection against hydrogen peroxide-induced cytotoxicity in PC12 cells by scutellarin. , 2004, Life sciences.

[4]  Xiaoyan Chen,et al.  Determination of scutellarin in rat plasma by high-performance liquid chromatography with ultraviolet detection. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[5]  Ying Wang,et al.  Protective effects of scutellarin on superoxide-induced oxidative stress in rat cortical synaptosomes. , 2003, Acta pharmacologica Sinica.

[6]  Yi-ming Liu,et al.  Study on pharmacokinetics of scutellarin in rabbits. , 2003, Yao xue xue bao = Acta pharmaceutica Sinica.

[7]  S. Sundlof,et al.  Interspecies allometric analysis of the comparative pharmacokinetics of 44 drugs across veterinary and laboratory animal species. , 1997, Journal of veterinary pharmacology and therapeutics.

[8]  C. Ruan,et al.  Effect of new-breviscapine on fibrinolysis and anticoagulation of human vascular endothelial cells. , 1992, Zhongguo yao li xue bao = Acta pharmacologica Sinica.

[9]  Q. Ping,et al.  [Pharmacokinetics of breviscapine liposomes following intravenous injection in Beagle dogs]. , 2006, Yao xue xue bao = Acta pharmaceutica Sinica.

[10]  L. Su.  Pharmacokinetics of Scutellarin in Dogs , 2003 .

[11]  Wan-sheng Chen,et al.  Studies on the flavone glycosides from the extract of Erigeron breviscapus , 2000 .

[12]  D. Wei.  Experimental research of PKC inhibitor, erigeron breviscapus on the ischemic/reperfusional brain injury , 1998 .